Cite

HARVARD Citation

    Douglas, R. et al. (2022). Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi Approach. Journal of neuro-ophthalmology. 42 (3), pp. 334-339. [Online]. 
  
Back to record